Kevin C. Johnson, Ph.D.

Research Scientist

The major focus of my research program is to investigate the epigenetic reprogramming along the continuum of cancer initiation to disease progression.

Visit The Verhaak Lab


Farmington, CT


More by @Kevin_C_Johnson

Recent Tweets

  • Kevin Johnson
    RT @anton_gh: 🔥🔥It was a pleasure writing this review for @NatureRevGenet on Extrachromosomal DNA amplifications in cancer with @_eunhee_yi…
  • Kevin Johnson
    @BTSMchat T4. I like a central resource. May help pts more easily navigate from results to what they might mean. Also being able to provide different types of plain language educational materials (text, videos, etc) in one location to reach the different style of learners out there #BTSM
  • Kevin Johnson
    @Sabine_NJ @BTSMchat @gliomaregistry @PECGSnetwork Yes, the paywalls are definitely a bummer and even happens to us researchers sometimes! #BTSM
  • Kevin Johnson
    @BTSMchat @gliomaregistry @PECGSnetwork T3. 2/2 There are many rigorous protocols in place to protect participants and participant information #BTSM
  • Kevin Johnson
    @BTSMchat T3. 1/2 Research results have not been directly returned to participants in the past. Instead, research results are usually shared via a scientific publication. However, we are conducting a study that would return results to participants via @gliomaregistry @PECGSnetwork #BTSM
  • Kevin Johnson
    @BTSMchat T2. No direct experience with pathology reports, however, for research we do our best to make the results more accessible by trying to remove jargon where possible and highlighting the most significant biomarkers #BTSM
  • Kevin Johnson
    @DoubleD2691 @BTSMchat @jacksonlab Thanks for doing the "homework"! Yes, the presentation referenced only tumors that were surgically excised. We're researching the factors that contribute to tumor progression and recurrence. #BTSM
  • Kevin Johnson
    @BTSMchat 👋 I am Kevin, a brain tumor research scientist at the @jacksonlab. Excited to participate in tonight's #BTSM discussion and learn from this community.

I am currently a postdoctoral associate in the laboratory of Dr. Roel Verhaak where my research has focused on brain tumor evolution and heterogeneity. To uncover the evolutionary trajectories that brain tumors take from initial diagnosis to disease recurrence, I co-led an international longitudinal brain tumor sequencing project. Computational analyses of these collected genomics data helped establish the order of somatic events throughout a tumor’s molecular life history and identified the most common evolutionary routes under selective therapeutic pressures. These findings were recently published in Nature, and I continue to be involved with projects that leverage this rich dataset. In a separate study, I have sought to deeply characterize the epigenetic heterogeneity that exists within brain tumors. To this end, I established a single-cell DNA methylation assay that enables genome-wide coverage of the epigenome and applied it to human brain tumor specimens.

            DOWNLOAD CV            

Kevin C. Johnson on ORCID

Education and Experience


Ph.D., Experimental and Molecular Medicine
Dartmouth College 2011 – 2016

B.S., Food Science and Technology
University of Massachusetts – Amherst 2007 – 2011


 The Jackson Laboratory for Genomic Medicine 2016 – Present
Postdoctoral Fellow; Advisor: Dr. Roel Verhaak
Genetic and epigenetic evolution of glioma

  • Co-led the international Glioma Longitudinal Analysis (GLASS) Consortium of glioma researchers to sequence initial and recurrent tumor pairs
  • Investigated the selective pressures that shape glioma evolution through multiple time point whole genome sequencing data
  • Established internal single-cell reduced representation bisulfite sequencing protocol to profile DNA methylation heterogeneity in glioma

Geisel School of Medicine at Dartmouth 2011 – 2016
Graduate Researcher; Advisor: Dr. Brock Christensen
Epigenetic biomarkers of disease progression in human cancers

  • Determined DNA methylation alterations across the spectrum of normal breast tissues, precancerous lesions, and invasive breast cancer in population-based studies
  • Applied integrative epigenomic analyses to simultaneously profile 5-methylcytosine and 5-hydroxymethylcytosine in glioblastoma and their relation with clinical outcomes

Honors and Accomplishments

2016 Neukom Prize for Outstanding Graduate Research in Computational Science

Albert J. Ryan Predoctoral Fellowship